Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes

European Journal of Pharmacology

Volumn 444, Issue 3, 2002, Pages 123-132

  Gluais, Pascale ^a   Bastide, Michèle ^a   Caron, Jacques ^b   Adamantidis, Monique ^a  

^a UNIV LILLE   (France)

^b Centre de Pharmacovigilance   (France)

Author keywords

Action potential; Delayed rectifier current; Heart; Inward rectifier current; Rabbit; Risperidone; Transient outward current

Indexed keywords

RISPERIDONE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PURKINJE FIBER; QT INTERVAL; RABBIT; ACTION POTENTIAL; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; HEART VENTRICLE; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ACTION POTENTIALS; ANIMAL; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLE; IN VITRO; MALE; MYOCYTES, CARDIAC; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PURKINJE FIBERS; RABBITS; RISPERIDONE; ANIMALS; HEART VENTRICLES;

EID: 0037204733     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01626-6     Document Type: Article

References (36)

1. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers
2. In vitro electrophysiological detection of iatrogenic arrhythmogenicity
3. Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers
4. Differential effects of antipsychotics and metabolites on action potentials recorded from rabbit Purkinje fibers: Relationship with clinical case reports of QT prolongation and torsade de pointes
5. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes
6. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart
7. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics
8. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: Experimental profile of BRL-32872
9. Overdose of risperidone
10. Overdose profiles of new antipsychotic agents
11. Drugs that prolong QT interval as an unwanted effect: Assessing their likelihood of inducing hazardous cardiac dysrhythmias
12. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs
13. Repercussion of pharmacologic reduction in ionic currents on action potential configuration in rabbit Purkinje fibers: Are they indicative of proarrhythmic potential?
14. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4
15. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone
16. Kr). Comparison to others neuroleptic drugs
17. Role of alpha1-blockade in congenital long QT syndrome: Investigation by exercise stress test
18. Toxicity following a single dose of risperidone for pediatric attention deficit hyperactivity disorder
19. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death
20. Acute poisoning by new psychotropic drugs
21. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications
22. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence
23. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
24. A case of risperidone overdose in early schizophrenia: A review of potential complications
25. Acute poisoning by risperidone and ionic and electrocardiographic changes
26. Risperidone overdose
27. Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers
28. Evaluation of drug-induced QT interval prolongation: Implications for drug approval and labelling
29. A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates
30. Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres
31. Fatal cardiac event following initiation of risperidone therapy
32. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
33. + current. Differential sensitivity to block by class III antiarrhythmic agents
34. Ks absent from undiseased human ventricular myocardium?
35. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: Time to revise current concepts
36. Kr: Model systems and relevance to human arrhythmias